DLHC

DLH Holdings Corp.
CAPPED RATING

DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. The company offers defense and veterans' health solutions, including healthcare, technology, and logistics solutions to the VA, Defense Health Agency, Tele-medicine and Advanced Technology Research Center, Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. It also provides a range of human services and solutions, which consists of monitoring and evaluation, electronic medical records migration, data collection and management, and nutritional and social health assessments; and IT system architecture design, migration plan, and ongoing maintenance services. In addition, the company offers public health and life sciences services, such as clinical trials, epidemiology studies, and disease prevention; and health promotion to underserved and at-risk communities through development of strategic communication campaigns, research on emerging trends, health informatics analyses, and application of best practices. It primarily serves the federal health services market. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.

DLH Holdings Corp. (DLHC) is rated C (2.2/5) on Deltasharpe Prism, scored against Industrials sector peers. Its strongest pillar is Value (B); its weakest is Growth (D-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
B
Factor Score 3.3 / 5.0
Growth
D-
Factor Score 1.0 / 5.0
Profitability
C
Factor Score 2.2 / 5.0
Momentum
C-
Factor Score 2.1 / 5.0
Revisions
C
Factor Score 2.3 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -5.3
EV / EBITDA 11.6
Rev Growth YoY -46.9%
Gross Margin 18.1%
Price Return 3M -22.2%
Price Return 12M -39.0%
Catalyst Signal 0.00
Market Cap $52.8M
TTM Revenue $253.5M
Price / Sales 0.2
ROE -20.8%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 B (3.3) D- (1.0) C (2.2) C- (2.1) C (2.3) C (2.2)
2026-11-04 B (3.3) D- (1.0) C (2.2) D+ (1.8) C (2.3) C- (2.1)
2026-10-28 B (3.3) D- (1.0) C- (2.1) D (1.2) C (2.2) C- (2.0)
2026-10-21 B (3.3) D- (1.0) C- (2.1) D+ (1.6) C (2.2) C- (2.0)
2026-10-14 B (3.3) D- (1.0) C- (2.1) D (1.4) C (2.2) C- (2.0)
Page 1 of 8
…